"Veeva is applying technologies that will shape the future of application delivery," said Raoul Lorenz, Chief Executive Officer, LORENZ Life Sciences Group. "LORENZ is investing resources to understand further collaboration opportunities, as well as the applicability of Veeva technologies to our customer base."LIQUENT, with more than 200 biopharmaceutical and life sciences clients worldwide, is a leading provider of software and professional services that support the regulatory business processes of global life sciences companies. Rick Riegel, Corporate Vice President of LIQUENT, a PAREXEL company, concluded, "Together with Veeva, we're providing an end-to-end solution for managing and publishing regulatory submissions in the cloud. When done right, cloud computing creates a true competitive advantage."
LIQUENT, EXTEDO And Lorenz Add Critical Publishing Capabilities To Industry's First Cloud-Based Application For Managing Submissions Content
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.